loading
전일 마감가:
$1.19
열려 있는:
$1.17
하루 거래량:
31,791
Relative Volume:
0.32
시가총액:
$21.42M
수익:
$411.00K
순이익/손실:
$-4.85M
주가수익비율:
-2.5909
EPS:
-0.44
순현금흐름:
$-4.88M
1주 성능:
-6.93%
1개월 성능:
-19.47%
6개월 성능:
-49.08%
1년 성능:
-63.72%
1일 변동 폭
Value
$1.11
$1.17
1주일 범위
Value
$1.11
$1.24
52주 변동 폭
Value
$1.11
$4.44

Lexaria Bioscience Corp Stock (LEXX) Company Profile

Name
명칭
Lexaria Bioscience Corp
Name
전화
250-765-6424
Name
주소
100 - 740 MCCURDY ROAD, KELOWNA
Name
직원
7
Name
트위터
Name
다음 수익 날짜
2025-04-28
Name
최신 SEC 제출 서류
Name
LEXX's Discussions on Twitter

LEXX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
LEXX
Lexaria Bioscience Corp
1.14 21.42M 411.00K -4.85M -4.88M -0.44
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.02 127.64B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
611.04 65.95B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
655.05 37.92B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
269.00 32.98B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
253.12 26.89B 3.81B -644.79M -669.77M -6.24

Lexaria Bioscience Corp 주식(LEXX)의 최신 뉴스

pulisher
May 03, 2025

Geode Capital Management LLC Increases Position in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World

May 03, 2025
pulisher
May 01, 2025

Lexaria Bioscience announces $2M registered direct offering; shares slip 19% - MSN

May 01, 2025
pulisher
Apr 30, 2025

Lexaria Bioscience stock hits 52-week low at $1.14 By Investing.com - Investing.com India

Apr 30, 2025
pulisher
Apr 30, 2025

Lexaria Bioscience stock hits 52-week low at $1.14 - Investing.com Australia

Apr 30, 2025
pulisher
Apr 28, 2025

Lexaria Announces Closing of $2 Million Registered Direct Offeri - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock - Yahoo Finance

Apr 28, 2025
pulisher
Apr 28, 2025

Lexaria Bioscience Secures $2 Million in Direct Stock Offering - TipRanks

Apr 28, 2025
pulisher
Apr 28, 2025

Lexaria Secures $2M Strategic Investment in Clean Direct Offering Amid Market Turbulence - Stock Titan

Apr 28, 2025
pulisher
Apr 28, 2025

Market Watch Highlights: Lexaria Bioscience Corp (LEXX) Ends on an Downturn Note at 1.35 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Lexaria Bioscience Corp (LEXX) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

Lexaria Raises $2 Million in Registered Direct Offering Despite Market Challenges - citybuzz -

Apr 28, 2025
pulisher
Apr 28, 2025

What is Zacks Small Cap’s Estimate for LEXX FY2025 Earnings? - Defense World

Apr 28, 2025
pulisher
Apr 25, 2025

Lexaria Bioscience (LEXX) Announces $2M Direct Offering | LEXX S - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Bioscience Secures $2 Million in Registered Direct Stock Offering - citybuzz -

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Announces $2 Million Registered Direct Offering of Commo - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Bioscience secures $2 million in direct offering By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Bioscience secures $2 million in direct offering - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Announces $2 Million Registered Direct Offering of Common Stock - TradingView

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Lands $2M Strategic Investment: Institutional Investor Backs Biotech at $1.00 Per Share - Stock Titan

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Bioscience (OTCMKTS:LXRP) versus U.S. Gold (NASDAQ:USAU) Critical Comparison - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

LEXX: Second Quarter Results - Yahoo Finance

Apr 24, 2025
pulisher
Apr 23, 2025

Lexaria Bioscience (LEXX) Advances in GLP-1 Technology Amid Indu - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Recent GLP-1-Industry Developments Highlight the Promise of Lexa - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology | LEXX Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology - TradingView

Apr 23, 2025
pulisher
Apr 23, 2025

Revolutionary Technology Could Solve GLP-1's Biggest Challenge: 64% Patient Dropout Rate - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

Lexaria Bioscience earnings beat by $0.02, revenue topped estimates - Investing.com

Apr 22, 2025
pulisher
Apr 19, 2025

Lexaria Corp. Announces Oil Discovery at PPF-12-7 well in Belmont Lake - marketscreener.com

Apr 19, 2025
pulisher
Apr 16, 2025

Lifezone Metals (NYSE:LZM) vs. Lexaria Bioscience (OTCMKTS:LXRP) Financial Review - Defense World

Apr 16, 2025
pulisher
Apr 14, 2025

Lexaria Bioscience Corp reports results for the quarter ended February 28Earnings Summary - TradingView

Apr 14, 2025
pulisher
Apr 14, 2025

Lexaria Bioscience Corp. SEC 10-Q Report - TradingView

Apr 14, 2025
pulisher
Apr 13, 2025

60,640 Shares in Lexaria Bioscience Corp. (NASDAQ:LEXX) Acquired by Raymond James Financial Inc. - Defense World

Apr 13, 2025
pulisher
Apr 07, 2025

Lexaria gets ethics board okay for oral GLP-1 study - MSN

Apr 07, 2025
pulisher
Apr 05, 2025

We Think Lexaria Bioscience (NASDAQ:LEXX) Needs To Drive Business Growth Carefully - Yahoo

Apr 05, 2025
pulisher
Apr 05, 2025

HighTower Advisors LLC Boosts Holdings in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

Lexaria Completes Enrollment for Pioneering Drug Delivery Study - TipRanks

Apr 03, 2025
pulisher
Apr 03, 2025

Lexaria completes enrollment for diabetes drug study - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Lexaria completes enrollment for diabetes drug study By Investing.com - Investing.com UK

Apr 03, 2025
pulisher
Apr 03, 2025

Lexaria's GLP-1 Study Hits Major Milestone with 20% Higher Patient Enrollment - Stock Titan

Apr 03, 2025
pulisher
Apr 02, 2025

Lexaria begins human trial for oral diabetes treatment - Investing.com India

Apr 02, 2025
pulisher
Apr 02, 2025

Lexaria begins human trial for oral diabetes treatment By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

Lexaria Bioscience Begins Human Trials for Oral Liraglutide Alternative - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Lexaria's Human GLP-1 Study #5 Begins Dosing - TradingView

Apr 02, 2025
pulisher
Apr 02, 2025

Revolutionary Oral GLP-1 Drug Challenges $1.8B Saxenda Market in New Trial - Stock Titan

Apr 02, 2025
pulisher
Apr 01, 2025

Lexaria Bioscience (LEXX) Expected to Announce Quarterly Earnings on Tuesday - Defense World

Apr 01, 2025
pulisher
Mar 18, 2025

Oral tirzepatide capsules match injection efficacy in Lexaria study By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Lexaria’s Oral Capsules Rival Injectable Weight Loss Treatment - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Oral tirzepatide capsules match injection efficacy in Lexaria study - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R) - ACCESS Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

Lexaria Bioscience's (LEXX) DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound - StreetInsider.com

Mar 18, 2025

Lexaria Bioscience Corp (LEXX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$72.03
price down icon 0.58%
$21.56
price up icon 0.47%
$32.77
price down icon 0.52%
$27.44
price down icon 2.29%
$104.51
price down icon 1.37%
biotechnology ONC
$253.01
price down icon 1.36%
자본화:     |  볼륨(24시간):